ATARA BIOTHERAPEUTICS INC (ATRA) Forecast, Price Target & Analyst Ratings

NASDAQ:ATRA • US0465132068

Current stock price

4.99 USD
-0.02 (-0.4%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ATARA BIOTHERAPEUTICS INC (ATRA).

Forecast Snapshot

Consensus Price Target

Price Target
$9.52
+ 90.78% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.41
Revenue Estimate
2.907M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
76.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.52
Upside
+ 90.78%
From current price of $4.99 to mean target of $9.52, Based on 10 analyst forecasts
Low
$4.04
Median
$6.12
High
$18.90

Price Target Revisions

1 Month
0.00%
3 Months
-52.54%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for ATRA. The average price target is 9.52 USD. This implies a price increase of 90.78% is expected in the next year compared to the current price of 4.99.
The average price target has been revised downward by 52.54% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ATRA Current Analyst RatingATRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ATRA Historical Analyst RatingsATRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.00%
ATRA was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about ATRA.
In the previous month the buy percentage consensus was at a similar level.
ATRA was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-13Canaccord GenuityDowngrade Buy -> Hold
2025-12-19Canaccord GenuityMaintains Buy -> Buy
2025-03-11Canaccord GenuityMaintains Buy -> Buy
2025-01-28HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-01-22HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-01-17Canaccord GenuityMaintains Buy -> Buy
2024-12-20Rodman & RenshawInitiate Buy
2024-11-13Canaccord GenuityMaintains Buy -> Buy
2024-08-21HC Wainwright & Co.Reiterate Neutral
2024-08-16MizuhoUpgrade Neutral -> Outperform
2024-08-13Canaccord GenuityMaintains Buy -> Buy
2024-07-17Goldman SachsMaintains Sell -> Sell
2024-05-22HC Wainwright & Co.Reiterate Neutral
2024-04-01StifelMaintains Hold -> Hold
2023-11-10Goldman SachsMaintains Sell -> Sell
2023-11-09MizuhoDowngrade Buy -> Neutral
2023-11-09Evercore ISI GroupDowngrade Outperform -> In-Line
2023-11-09HC Wainwright & Co.Downgrade Buy -> Neutral
2023-09-26HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-21CitigroupMaintains Sell -> Sell
2023-08-09EF HuttonReiterate Buy -> Buy
2023-06-14HC Wainwright & Co.Maintains Buy -> Buy
2023-05-09Canaccord GenuityMaintains Buy
2023-02-09EF HuttonReiterate Buy
2023-02-09HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.41
Revenue Estimate
2.907M
Revenue Q2Q
-97.04%
EPS Q2Q
-111.80%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
67.65%
Revenue (3 Months)
-93.33%
EPS (1 Month)
0.00%
EPS (3 Months)
-119.38%

Next Earnings Summary

ATRA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.41 USD and the consensus revenue estimate is 2.91M USD.
The next earnings revenue estimate has been revised downward by 93.33% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ATRA revenue by date.ATRA revenue by date.
8.573M
-86.51%		128.94M
1,404.02%		120.772M
-6.33%		31.858M
-73.62%		31.382M
-1.49%		50.887M
62.15%		92.31M
81.40%		102.51M
11.05%		85.68M
-16.42%		83.64M
-2.38%		79.56M
-4.88%
EBITDA
YoY % growth
ATRA ebitda by date.ATRA ebitda by date.
-264.447M
1.66%		-73.28M
72.29%		54.687M
174.63%		-3.774M
-106.90%		-5.712M
-51.35%		-2.448M
57.14%		-120.36M
-4,816.67%		12.24M
110.17%		88.74M
625.00%		134.64M
51.72%		N/A
EBIT
YoY % growth
ATRA ebit by date.ATRA ebit by date.
-269.276M
1.92%		-78.331M
70.91%		52.571M
167.11%		-9.68M
-118.41%		-7.259M
25.01%		-16.32M
-124.81%		53.55M
428.13%		59.16M
10.48%		34.68M
-41.38%		30.6M
-11.76%		26.52M
-13.33%
Operating Margin
ATRA operating margin by date.ATRA operating margin by date.
-3,140.98%-60.75%43.53%-30.39%-23.13%-32.07%58.01%57.71%40.48%36.59%33.33%
EPS
YoY % growth
ATRA eps by date.ATRA eps by date.
-65.50
3.68%		-12.97
80.20%		3.12
124.06%		-1.15
-136.94%		-1.29
-11.95%		-1.08
16.60%		2.28
312.32%		2.50
9.60%		3.81
52.34%		3.68
-3.48%		3.43
-6.93%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.41
-111.80%		-0.36
-287.89%		-0.32
1.19%		-0.08
67.36%
Revenue
Q2Q % growth		2.907M
-97.04%		3.468M
-80.27%		4.08M
18.16%		6.732M
322.07%
EBITDA
Q2Q % growth		-2.244M
-104.12%		-1.836M
-127.20%		-1.632M
-10.27%		1.938M
142.55%
EBIT
Q2Q % growth		-3.195M
-106.06%		-2.888M
-161.18%		-2.687M
24.24%		-808.35K
38.62%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ATRA Yearly Revenue VS EstimatesATRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 20M 40M 60M 80M 100M
ATRA Yearly EPS VS EstimatesATRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -50 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-32.85%
EPS Next 5 Year
-4.30%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.70%
Revenue Next 5 Year
-3.74%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-27.38%
EBIT Next 5 Year
-19.71%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ATARA BIOTHERAPEUTICS INC / ATRA Forecast FAQ

What do analysts expect the price target to be for ATARA BIOTHERAPEUTICS INC (ATRA)?

10 analysts have analysed ATRA and the average price target is 9.52 USD. This implies a price increase of 90.78% is expected in the next year compared to the current price of 4.99.

When does ATARA BIOTHERAPEUTICS INC (ATRA) report earnings?

ATARA BIOTHERAPEUTICS INC (ATRA) will report earnings on 2026-05-06.

Can you provide the consensus estimates for ATARA BIOTHERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of ATARA BIOTHERAPEUTICS INC (ATRA) is -0.41 USD and the consensus revenue estimate is 2.91M USD.

How many analysts cover ATARA BIOTHERAPEUTICS INC (ATRA) stock?

The number of analysts covering ATARA BIOTHERAPEUTICS INC (ATRA) is 10.